Derringer Fenton
Nurse Practitioner · Springfield, MONPI 1386211308
Payments from drug & device makers
Across 133 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$602
- Neurocrine Biosciences, Inc.$299
- Teva Pharmaceuticals USA, Inc.$259
- Collegium Pharmaceutical, Inc.$212
- Corium, LLC$143
- Otsuka America Pharmaceutical, Inc.$140
- plus $702 from 17 others
What the payments were for
- Food & beverage$2,25696%
- Education$1014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $602 |
| Neurocrine Biosciences, Inc. | 12 | $299 |
| Teva Pharmaceuticals USA, Inc. | 16 | $259 |
| Collegium Pharmaceutical, Inc. | 12 | $212 |
| Corium, LLC | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 8 | $140 |
| Alkermes, Inc. | 7 | $134 |
| Indivior Inc. | 4 | $72 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $66 |
| Braeburn Inc. | 3 | $54 |
| Viiv Healthcare Company | 2 | $46 |
| Lundbeck LLC | 2 | $37 |
| Johnson & Johnson | 2 | $34 |
| Astellas Pharma US Inc | 1 | $30 |
| Exact Sciences | 2 | $29 |
| Globus Medical | 1 | $27 |
| Dexcom, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Novo Nordisk | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,357 in reported general payments places this provider in the 85th percentile of 1,898 nurse practitioner providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 22 | $29,896 |
| LinzessLinaclotide | 26 | $19,934 |
| EliquisApixaban | 20 | $19,377 |
| OzempicSemaglutide | 18 | $18,650 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 26 | $16,743 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 169 | $15,190 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $14,740 |
| Spiriva HandihalerTiotropium Bromide | 20 | $12,997 |
| Varenicline Tartrate | 16 | $5,743 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,852 |
| Gabapentin | 195 | $2,932 |
| Buprenorphine Hcl | 83 | $2,162 |
| Baclofen | 113 | $1,846 |
| Pregabalin | 76 | $1,632 |
| Duloxetine Hcl | 68 | $1,608 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $20 | $29,89622 claims |
| AbbVieLinzess | $602 | $19,93426 claims |
| Novo NordiskOzempic | $15 | $18,65018 claims |
| Indivior Inc.Suboxone | $72 | $16,74326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,898 nurse practitioner providers in Missouri.
Other nurse practitioner in Springfield
- Michelle DickensSpringfield$59K
- Sara HillSpringfield$9K
- Lisa PotthoffSpringfield$9K
- Edrie WichernSpringfield$9K
- Leslie LeeSpringfield$8K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.